Mycoplasmosis. Mycoplasmosis symptoms. Treatment of mycoplasmosis.

MYCOPLASMOSIS is an acute infectious disease caused by mycoplasma.

RESPIRATORY MYCOPLASMOSIS, progresses like an acute respiratory infection or pneumonia. Lesion of the respiratory system is caused by the pneumonia mycoplasma (Mycoplasma pneumoniae). Mycoplasmae are resistant to sulfanilamides, penicillin, streptomycin but are sensitive to the antibiotics of the tetracycline group. The mucous membranes of the respiratory and the urogenital tracts are the gate for the infection (depending on the type of the infectious agent) and the focal point of inflammation. The infection is transmitted through droplet inhalation or during sex. The incubation period may range from 4 to 25 days (the 7-14 days latency is commoner).

RESPIRATORY MYCOPLASMOSIS SYMPTOMS. The infection may develop as an acute respiratory disease, pneumonia, abacterial (non-gonococcal) uretritis or a gynecological inflammatory disease. The mycoplasmal respiratory infection is characterized by pharyngitis, rhinopharyngitis. The general condition is satisfactory, the temperature is subfebrile. Acute pneumonias start with chills, rising temperature, and general intoxication symptoms. The laboratory methods used to confirm the diagnosis are serological reactions (IHAR and CBR). The diagnosis is confirmed by a 4-fold and bigger growth of the antibodies titre. Respiratory mycoplasmosis treatment

Mycoplasmosis of urogenital system is a group of inflammatory diseases caused by pathogenic bacteria – mycoplasma M. hominis and T-mycoplasma. During inflammatory conditions of the urogenital system mycoplasma is found responsible in 60-90% cases, it can be revealed in 5-15% of healthy persons. The latter fact attests to existence of an asymptomatic form of the infection, which can be triggered active by pregnancy, delivery, colds and stresses. Mycoplasmosis is primarily a STD other ways of transmission being very rare. The length of the incubation period is from 3 days to 5 weeks, generally amounting to 15-19 days in the average. In males lesion affects urethra, parauretral ducts, seminal vesicles, testicles, epididymises, prostate, bladder; in females lesion may spread to urethra, parauretral ducts, vulva, Bartholin’s glands, cervix, uterus, fallopian tubes, ovaries, peritoneum of pelvis minor. The lesions are characterized by a variety of clinical forms ranging from acute to minimal torpid manifestations. Chronic torpid mycoplasmosis prevails.

SYMPTOMS OF UROGENITAL MYCOPLASMOSIS. In the clinical perspective urogenital mycoplasmosis does not differ much from other STD’s (gonorrhea, trichomoniasis). Some patients have no notable sensations while the complains in other cases vary a lot. When the urethral canal in males is affected, scarce morning discharge may be observed. In the majority of cases lesion of the epididymis manifests itself in vague pulling pain in the groin, perineum, scrotum, followed by enlargement of the epididymis, and the scrotum hyperemia.

Mycoplasmosis may lead to premature delivery, early discharge of the amniotic fluid, fever during and after delivery in mothers, development of pneumonia, meningitis in children, morphological changes in sperm. Treatment of urogenital mycoplasmosis